Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
Produktmerkmale
This is a synthetic peptide designed for use in combination with anti-ELL antibody (Catalog #: ARP30105_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
ELL
(Elongation Factor RNA Polymerase II (ELL))
Synonyme
wu:fc60b11 Peptide, zgc:63836 Peptide, C19orf17 Peptide, ELL1 Peptide, MEN Peptide, PPP1R68 Peptide, Ell1 Peptide, Men Peptide, elongation factor for RNA polymerase II Peptide, elongation factor RNA polymerase II Peptide, ELL Peptide, ell Peptide, Ell Peptide
Hintergrund
ELL was shown to encode a previously uncharacterized elongation factor that can increase the catalytic rate of RNA polymerase II transcription by suppressing transient pausing by polymerase at multiple sites along the DNA. Functionally, ELL resembles Elongin (SIII), a transcription elongation factor regulated by the product of the von Hippel-Lindau (VHL) tumor suppressor gene.
Alias Symbols: MEN, ELL1, PPP1R68, C19orf17
Protein Interaction Partner: EAF1,EAF2,HNRNPU,POLR2A,SNF8,TFPT,TP53,EAF1,EAF2,SIRT2,SNF8,TP53,USPL1,ZHX1